Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
An Australian-led research team have mapped pancreatic cancer genomes and identified four distinct subgroups with potential clinical utility. The study marks a step towards personalised disease management for individual pancreatic cancer patients.
Pancreatic cancer is the fourth most common cause of cancer death. Currently, most pancreatic cancer patients do not respond to treatments.
Published in Nature, the findings are one of the most significant advances in pancreatic cancer in the last 50 years. The headline discovery was that pancreatic cancer can be divided into four subgroups that differentiate tumours, based on variations in chromosomal structure: these subtypes were termed stable, locally rearranged, scattered and unstable.
http://www.phgfoundation.org/news/16579
Pancreatic cancer is the fourth most common cause of cancer death. Currently, most pancreatic cancer patients do not respond to treatments.
Published in Nature, the findings are one of the most significant advances in pancreatic cancer in the last 50 years. The headline discovery was that pancreatic cancer can be divided into four subgroups that differentiate tumours, based on variations in chromosomal structure: these subtypes were termed stable, locally rearranged, scattered and unstable.
http://www.phgfoundation.org/news/16579